MMP2 Protein
Introduction
Mmp2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox .infobox-protein"> [@sternlicht2001]
<table> [@yong2001]
<tr><th colspan="2">MMP2 Protein</th></tr> [@brkic2015]
<tr><td><b>Protein Name</b></td><td>Matrix Metalloproteinase-2</td></tr> [@cauwe2009]
<tr><td><b>Gene</b></td><td>[MMP2](/genes/mmp2)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P08253](https://www.uniprot.org/uniprot/P08253)</td></tr>
<tr><td><b>PDB IDs</b></td><td>1CK7, 1EAK, 1G5K</td></tr>
<tr><td><b>Molecular Weight</b></td><td>73.9 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Extracellular matrix, Cell surface</td></tr>
<tr><td><b>Protein Family</b></td><td>MMP family (gelatinases)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's" style="color:#ef9a9a">ALZHEIMER'S</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">400 edges</a></td>
</tr>
</table>
</div>
Overview
...MMP2 Protein
Introduction
Mmp2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox .infobox-protein"> [@sternlicht2001]
<table> [@yong2001]
<tr><th colspan="2">MMP2 Protein</th></tr> [@brkic2015]
<tr><td><b>Protein Name</b></td><td>Matrix Metalloproteinase-2</td></tr> [@cauwe2009]
<tr><td><b>Gene</b></td><td>[MMP2](/genes/mmp2)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P08253](https://www.uniprot.org/uniprot/P08253)</td></tr>
<tr><td><b>PDB IDs</b></td><td>1CK7, 1EAK, 1G5K</td></tr>
<tr><td><b>Molecular Weight</b></td><td>73.9 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Extracellular matrix, Cell surface</td></tr>
<tr><td><b>Protein Family</b></td><td>MMP family (gelatinases)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's" style="color:#ef9a9a">ALZHEIMER'S</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">400 edges</a></td>
</tr>
</table>
</div>
Overview
The MMP-2 (Matrix Metalloproteinase-2) protein, also known as gelatinase A, is a zinc-dependent endopeptidase that degrades extracellular matrix components. MMP-2 is secreted as a proenzyme (pro-MMP-2) and activated by proteolytic cleavage. In the brain, MMP-2 regulates synaptic plasticity, [blood-brain barrier](/entities/blood-brain-barrier) remodeling, and neuroinflammation. While MMP-2 can contribute to [amyloid-beta](/proteins/amyloid-beta) degradation, it also participates in pathological tissue remodeling in Alzheimer's disease. In Parkinson's disease, MMP-2 is involved in dopaminergic neuron survival and disease progression.
MMP-2 (gelatinase A) is a zinc-dependent endopeptidase that degrades extracellular matrix components and is involved in tissue remodeling and neuroinflammation.
Structure
MMP2 is a 660-amino acid protein with a signal peptide (1-20), propeptide (21-84) containing a cysteine switch, catalytic domain (85-211) with zinc-binding motif HEXGHNL, fibronectin type II repeats (211-438) for gelatin binding, hinge region (439-469), and hemopexin domain (470-660). The propeptide maintains latency until cleaved for activation.
Normal Function
MMP-2 degrades gelatin (denatured collagen), type IV collagen, elastin, and other ECM components. It is secreted as a proenzyme (pro-MMP-2) and activated by membrane-type MMPs (MT1-MMP/MMP14). MMP-2 is involved in tissue remodeling, wound healing, blood-brain barrier (BBB) breakdown, synaptic plasticity, and neuroinflammation. It plays roles in Aβ degradation in AD and dopaminergic neuron survival in PD.
Role in Disease
Elevated MMP-2 is seen in AD (associated with amyloid pathology and BBB dysfunction), PD (dopaminergic region), MS (active lesions), and after stroke/TBI (contributes to secondary damage). MMP-2 deficiency worsens outcomes in some injury models.
Therapeutic Targeting
Broad-spectrum MMP inhibitors (batimastat, marimastat) failed in cancer trials due to side effects. Selective MMP-2 inhibitors are being developed. Natural compounds (tetrahydroxy stilbene, ebselen) have shown MMP-2 modulating activity. Timing and context-specific effects complicate therapeutic targeting.
Background
The study of Mmp2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- MMP2 Gene
- [Growth Factor Signaling Pathway](/therapeutics/neurotrophic-factor-therapies)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [UniProt: P08253](https://www.uniprot.org/uniprot/P08253)
- [PDB: 1CK7, 1EAK, 1G5K](https://www.ebi.ac.uk/pdbe/search?q=MMP2)
- [NCBI Protein: MMP2](https://www.ncbi.nlm.nih.gov/protein/?term=MMP2)
Expression Pattern
Tissue Distribution
MMP-2 is widely expressed in various tissues:
- Brain: Neurons, astrocytes, microglia, endothelial cells
- Connective tissue: Fibroblasts, chondrocytes
- Muscle: Smooth muscle cells, skeletal muscle
- Vascular: Endothelial cells, vascular smooth muscle
- Immune cells: Macrophages, neutrophils
Brain Region Specificity
In the brain, MMP-2 expression is particularly high in:
- Hippocampal neurons (CA1, CA3)
- Cerebral cortex pyramidal neurons
- Cerebellar Purkinje cells
- Hypothalamic nuclei
- Subventricular zone (neurogenic niche)
Molecular Mechanisms
Activation Cascade
MMP-2 activation requires a complex cascade:
[
MMP-2 degrade- Fibronectin: ECM glycoprotein
- Aggrecan: Cartilage proteoglycan
- IL-1β: Proinflammatory cytokine
- TNF-α precursor: Inflammatory mediator
Role in Neurodegeneration
Alzheimer's Disease
MMP-2 has complex roles in AD:
Protective Effects:
- Degrades Aβ peptides
- Clears amyloid deposits
- Promotes Aβ clearance across BBB
Pathological Effects:
- Degrades synaptic proteins
- Disrupts blood-brain barrier
- Promotes neuroinflammation
- Facilitates tau pathology spread
Parkinson's Disease
In PD, MMP-2 modulates:
- Dopaminergic neuron survival: Via neurotrophic factor processing
- α-Synuclein aggregation: Interaction with aggregation pathway
- Neuroinflammation: Glial activation state
- Blood-brain barrier integrity: Permeability changes
Amyotrophic Lateral Sclerosis
MMP-2 in ALS:
- Elevated in spinal cord of ALS patients
- Contributes to motor neuron injury
- Facilitates inflammatory cell infiltration
- Potential therapeutic target
Therapeutic Targeting
MMP-2 Inhibitors
| Compound | Type | Status | Notes |
|----------|------|--------|-------|
| Batimastat | Broad-spectrum | Preclinical | Poor bioavailability |
| Marimastat | Broad-spectrum | Clinical trials | GI side effects |
| Selective inhibitors | MMP-2 specific | Research | In development |
Challenges
- Broad-spectrum inhibitors cause side effects
- Timing of intervention critical
- Compensatory upregulation possible
Biomarkers
MMP-2 levels as potential biomarkers:
- CSF MMP-2: Elevated in AD, PD
- Blood MMP-2: Peripheral marker
- Activity ratios: MMP-2/TIMP balance
Animal Models
- MMP-2 knockout mice: Protected from BBB damage after stroke
- Transgenic MMP-2 overexpression: Increased neuroinflammation
- AAV-mediated MMP-2: Modulates synaptic plasticity
References
[Nagase H, Woessner JF, Matrix metalloproteinases (1999)](https://pubmed.ncbi.nlm.nih.gov/10419415/)
[Sternlicht MD, Werb Z, How MMPs regulate cell behavior (2001)](https://pubmed.ncbi.nlm.nih.gov/11687497/)
[Yong VW, et al, Metalloproteinases in neurodegeneration (2001)](https://pubmed.ncbi.nlm.nih.gov/11433377/)
[Brkic M, et al, MMP2 in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25753823/)
[Cauwe B, et al, MMPs in ALS (2009)](https://pubmed.ncbi.nlm.nih.gov/19643024/)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [SASP-Mediated Cholinergic Synapse Disruption](/hypothesis/h-1acdd55e) — <span style="color:#ffd54f;font-weight:600">0.56</span> · Target: MMP2/MMP9